{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T23:01:26Z","timestamp":1766530886874,"version":"3.32.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ymgme.2023.107644","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T17:51:35Z","timestamp":1687974695000},"page":"107644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of enzyme replacement therapy on bone density in late onset Pompe disease"],"prefix":"10.1016","volume":"140","author":[{"given":"Mahima","family":"Avanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod Carlo","family":"Columbres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahseen","family":"Mozaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Kimonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107644_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-015-0412-3","article-title":"Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group","volume":"15","author":"Al Jasmi","year":"2015","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgme.2023.107644_bb0010","first-page":"82","article-title":"Clinical features of Pompe disease","volume":"32","author":"Manganelli","year":"2013","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymgme.2023.107644_bb0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijns6010009","article-title":"The first year experience of newborn screening for Pompe disease in California","volume":"6","author":"Tang","year":"2020","journal-title":"Int. J. Neonatal. Screen."},{"key":"10.1016\/j.ymgme.2023.107644_bb0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/gim.2012.44","article-title":"The emerging phenotype of long-term survivors with infantile Pompe disease","volume":"14","author":"Prater","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107644_bb0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2005-837543","article-title":"Enzyme replacement therapy in classical infantile Pompe disease: results of a ten-month follow-up study","volume":"36","author":"Klinge","year":"2005","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.ymgme.2023.107644_bb0030","series-title":"Genereviews","first-page":"1","article-title":"Pompe disease","author":"Leslie","year":"2007"},{"key":"10.1016\/j.ymgme.2023.107644_bb0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ncl.2014.04.010","article-title":"Pompe disease: literature review and case series","volume":"32","author":"Dasouki","year":"2014","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.ymgme.2023.107644_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5812\/ijem.4967","article-title":"Bone density in patients with late onset pompe disease","volume":"10","author":"Papadimas","year":"2012","journal-title":"Int. J. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2023.107644_bb0045","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of Alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2023.107644_bb0050","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S1474-4422(21)00241-6","article-title":"Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial","volume":"vol. 20","author":"Diaz-Manera","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ymgme.2023.107644_bb0055","first-page":"132","article-title":"Recombinant human acid \u03b1-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107644_bb0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S2352-4642(21)00308-4","article-title":"Effect of alglucosidase alfa dosage on survival and walking ability in patients with classic infantile Pompe disease: a multicentre observational cohort study from the European Pompe consortium","volume":"6","author":"Ditters","year":"2022","journal-title":"Lancet Child Adolesc. Heal."},{"issue":"13","key":"10.1016\/j.ymgme.2023.107644_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.21037\/atm.2019.06.48","article-title":"Variable clinical features and genotype-phenotype correlations in 18 patients with late-onset Pompedisease","volume":"7","author":"Alandy-dy","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymgme.2023.107644_bb0070","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.ymgme.2023.107644_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00794","article-title":"Neuromuscular diseases and bone","volume":"10","author":"Iolascon","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)."},{"year":"2014","series-title":"The Musculoskeletal System in Pompe Disease. Pathology, Consequences and Treatment Options","author":"Van Den Berg","key":"10.1016\/j.ymgme.2023.107644_bb0080"},{"key":"10.1016\/j.ymgme.2023.107644_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2014.00154","article-title":"The contribution of experimental in vivo models to understanding the mechanisms of adaptation to mechanical loading in bone","volume":"5","author":"Meakin","year":"2014","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.ymgme.2023.107644_bb0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","article-title":"Low bone mass in Pompe disease. Muscular strength as a predictor of bone mineral density","volume":"47","author":"van den Berg","year":"2010","journal-title":"Bone."},{"key":"10.1016\/j.ymgme.2023.107644_bb0095","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe\u2019s disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2023.107644_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00247-007-0428-y","article-title":"Fractures in children with Pompe disease: a potential long-term complication","volume":"37","author":"Case","year":"2007","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.ymgme.2023.107644_bb0105","first-page":"99","article-title":"A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology","volume":"4","author":"Bobo Tanner","year":"2012","journal-title":"Open Access Rheumatol. Res. Rev."},{"key":"10.1016\/j.ymgme.2023.107644_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-017-2681-y","article-title":"Improvement of bone mineral density after enzyme replacement therapy in Chinese late-onset Pompe disease patients","volume":"10","author":"Sheng","year":"2017","journal-title":"BMC Res. Notes."},{"key":"10.1016\/j.ymgme.2023.107644_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2017.06.010","article-title":"Body composition by DXA","volume":"104","author":"Shepherd","year":"2017","journal-title":"Bone."},{"key":"10.1016\/j.ymgme.2023.107644_bb0120","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jc.2014-2763","article-title":"Prevalence of asymptomatic vertebral fractures in late-onset pompe disease","volume":"100","author":"Bertoldo","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2023.107644_bb0125","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18773\/austprescr.2016.020","article-title":"Bone mineral density: testing for osteoporosis","volume":"39","author":"Sheu","year":"2016","journal-title":"Aust. Prescr."},{"key":"10.1016\/j.ymgme.2023.107644_bb0130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12018-009-9064-4","article-title":"T-scores and Z-scores","volume":"8","author":"Carey","year":"2010","journal-title":"Clin. Rev. Bone Miner. Metab."},{"key":"10.1016\/j.ymgme.2023.107644_bb0135","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2019.11889","article-title":"Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial","volume":"322","author":"Burt","year":"2019","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"10.1016\/j.ymgme.2023.107644_bb0140","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Diagnosis, osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention","year":"2001","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.ymgme.2023.107644_bb0145","first-page":"25","article-title":"The effect of muscle dysfunction on bone mass and morphology","volume":"10","author":"Gross","year":"2010","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.ymgme.2023.107644_bb0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2010.09.002","article-title":"Body composition analysis in late-onset Pompe disease","volume":"102","author":"Papadimas","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107644_bb0155","series-title":"JIMD Rep","first-page":"81","article-title":"Vivo bone architecture in Pompe disease using high-resolution peripheral computed tomography","author":"Khan","year":"2012"},{"key":"10.1016\/j.ymgme.2023.107644_bb0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ogc.2018.07.012","article-title":"Bone health during the menopause transition and beyond","volume":"45","author":"Karlamangla","year":"2018","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.ymgme.2023.107644_bb0165","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1759720X11430858","article-title":"Aging and bone loss: new insights for the clinician","volume":"4","author":"Demontiero","year":"2012","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.ymgme.2023.107644_bb0170","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10522-017-9732-6","article-title":"Exercise and bone health across the lifespan","volume":"18","author":"Santos","year":"2017","journal-title":"Biogerontology."},{"key":"10.1016\/j.ymgme.2023.107644_bb0175","doi-asserted-by":"crossref","DOI":"10.4081\/ejtm.2021.9798","article-title":"Exercise, nutrition and enzyme replacement therapy are efficacious in adult Pompe patients: report from EPOC consortium","volume":"31","author":"Angelini","year":"2021","journal-title":"Eur. J. Transl. Myol."},{"key":"10.1016\/j.ymgme.2023.107644_bb0180","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s001980200098","article-title":"Embryo\/fetus radiation dose and risk from dual X-ray absorptiometry examinations","volume":"13","author":"Damilakis","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.ymgme.2023.107644_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jocd.2013.02.005","article-title":"Dose absorption in lumbar and femoral dual energy x-ray absorptiometry examinations using three different scan modalities: an anthropomorphic phantom study","volume":"16","author":"Bandirali","year":"2013","journal-title":"J. Clin. Densitom."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223002743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T17:13:02Z","timestamp":1735233182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223002743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1096719223002743"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107644","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of enzyme replacement therapy on bone density in late onset Pompe disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107644"}}